Manual: increasing access to hepatitis C testing and care for people who inject drugs

Lisbon July 2021

Series type: Manuals

Summary

This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who use drugs. In particular, it focuses on HCV testing in harm reduction and drug treatment settings.

Download as PDF

Table of contents

  • Acknowledgements
  • Preface
  • Increasing access to hepatitis C testing and care for people who inject drugs: why is it so important?
  • Introducing the diagnostic process
  • Step 1: Assessing the need for hepatitis C testing in drug services
  • Step 2: Multi-stakeholder consultation to identify barriers and solutions
  • Step 3: Ensuring monitoring and evaluation
  • Appendix 1: Checklist of barriers for HCV testing
  • Appendix 2: Three round-table scenarios
  • References
cover of increasing access to hepatitis C testing and care for people who inject drugs
Pub. Author: 
EMCDDA
Pages: 
30
ISBN: 
978-92-9497-645-1
ISSN: 
1725-339X
Pub. DOI: 
10.2810/033126
Catalog Number: 
TDMA21002ENN

Related links: 

Main subject

drug-related infectious diseases

Keywords

drug-related infectious diseases
harm reduction
health harms of drug use
hepatitis B
hepatitis C
HIV
injecting drug use
preventing infectious diseases
problem drug use

Target audience

policymaker
practitioner

Publications

Loading